Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

March 20, 2007; 68 (12) Articles

A longitudinal study on quality of life and depression in ALS patient–caregiver couples

A. Gauthier, A. Vignola, A. Calvo, E. Cavallo, C. Moglia, L. Sellitti, R. Mutani, A. Chiò
First published March 19, 2007, DOI: https://doi.org/10.1212/01.wnl.0000257093.53430.a8
A. Gauthier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Vignola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Calvo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Cavallo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Moglia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Sellitti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Mutani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Chiò
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
A longitudinal study on quality of life and depression in ALS patient–caregiver couples
A. Gauthier, A. Vignola, A. Calvo, E. Cavallo, C. Moglia, L. Sellitti, R. Mutani, A. Chiò
Neurology Mar 2007, 68 (12) 923-926; DOI: 10.1212/01.wnl.0000257093.53430.a8

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
610

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Objectives: To evaluate the modification of quality of life (QoL) and depression in a series of amyotrophic lateral sclerosis (ALS) patient–caregiver couples during a period of 9 months and compare them to patients’ ALS Functional Rating Scale (ALS-FRS).

Methods: Depression was assessed with Zung Depression Scale (ZDS) and QoL with McGill Quality of Life Questionnaire (MQoL). Caregivers’ burden was assessed with Caregiver Burden Inventory (CBI), and patients’ feeling to be a burden with the Self-Perceived Burden Scale (SPBS).

Results: Thirty-one ALS patient–caregiver couples were interviewed at baseline and after 9 months. The mean ALS-FRS score was 28.7 (SD 7) at baseline and 24.1 (6.9) at the second interview (p = 0.0001). Patients’ mean MQoL score slightly increased from 6.8 (1.6) to 7 (1.1) (p = 0.07); their ZDS score slightly increased (43.2 [8.7] at baseline and 45.7 [9.3] at the second interview) but they remained in the not depressed range. Caregivers’ mean MQoL score slightly decreased, and their mean ZDS increased from 38.9 (8.1) to 42.2 (8.7) (p = 0.02). The mean CBI score increased from 50.3 (17.6) to 55.8 (16.4) (p = 0.03).

Conclusions: We found a substantial steadiness of quality of life and depression in patients with amyotrophic lateral sclerosis over a 9-month period, vs a significant increase of burden and depression of their caregivers.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of the CNS with an unknown etiology. It is characterized by a progressive loss of cortical and spinal motor neurons, causing bulbar and spinal palsy. Usually death occurs 2 to 4 years after onset, mostly due to respiratory failure. Despite the extreme severity of ALS, patients with ALS tend to be characterized by a sort of stoical indifference toward their condition1; in cross-sectional studies the rate of depression in patients with ALS has been estimated between 11% and 48%, according to the rating scales utilized and the patients’ clinical status.2–6 Also, ALS caregivers’ attitude and reactions appear somehow different from those who care for patients with other severe and chronic neurologic conditions, such as Alzheimer disease, Parkinson disease, and multiple sclerosis.7–9 However, it is not clear whether ALS patients’ and caregivers’ attitudes modify with disease progression.

In order to gain a better understanding about the time trends of patients’ quality of life (QoL) and depression with the worsening of their clinical status, we performed a longitudinal study on a series of patients with ALS attending our facility. We also assessed their caregivers, in order to find out whether their QoL, depression, and burden worsened due to the physical decline of the persons they were caring for.

Methods.

We recruited 55 consecutive patients with probable, probable laboratory-supported, or definite ALS, according to revised El Escorial criteria,10 visited in our ALS clinic or at patients’ homes by one of the authors during a 2-month period (March to April 2004). Patients with clinically overt frontotemporal dementia (FTD), clinically evaluated, were excluded from the study. However, FTD was not formally tested. After having signed an informed consent, the patient and his or her caregiver were interviewed by the same psychologist, with the same modalities, and, when possible, in the same setting; all couples were interviewed separately. The second interview was scheduled 9 months (±1 month) after the baseline interview. The second interview was administered by the same psychologist, with analogous procedure and setting, whenever possible. The caregiver was the person indicated by the patient as his or her main informal caregiver, in most instances a family member. The caregiver was the same in both interviews. Professional (paid) caretakers, such as nurses, were not considered in this study. The research was approved by our Institutional Review Board.

Patients underwent the following tests: Zung Depression Scale (ZDS, range 20 to 80, with scores up to 50 indicating not depressed; 50 to 59 signifying minimal to mild depression; 60 to 69 indicating moderate depression; and 70+ indicating severe depression)11; Self-Perceived Burden Scale (SPBS, range 25 to 125, with higher scores indicating that the patients perceived themselves to cause a higher burden to their caregivers)12; and McGill Quality of Life Questionnaire (MQoL, range 1 to 10, with 5 subscales also ranging from 1 to 10, where higher scores indicate greater levels of well being).13 All scales have been used in ALS and have been validated in other disorders.4,9 The patients’ physical status was measured with the Amyotrophic Lateral Sclerosis–Functional Rating Scale (ALS-FRS, range 0 to 40, with higher scores indicating a better physical status). We also subdivided the ALS-FRS in four subscales: bulbar symptoms (range 0 to 12); upper limbs (range 0 to 12); lower limbs (range 0 to 12); and respiration (range 0 to 4).

Caregivers were administered ZDS, MQoL, and Caregiver Burden Inventory (CBI, range 0 to 100, with 5 subscales each with a range of 0 to 20, where higher scores stand for a heavier burden).14

Comparisons were performed with Student t-test and Fisher exact test. All tests were two-tailed. A p level of < 0.05 was considered significant. Since multiple correlations were performed, Bonferroni correction was applied. All statistical calculations were made using the Statistical Package for Social Sciences (SPSS), version 12.0 for Windows (SPSS, Chicago, IL).

Results.

We performed two consecutive interviews with 31 (56.4%) of the 55 patient–caregiver couples who originally entered the study. The reasons for dropouts were death (20 patients), unfeasibility to administer the battery of tests because of patients’ worsening physical status (2 patients), and withdrawal of consent (2 patients). The patients who were not interviewed two times were significantly older and had a worse ALS-FRS score at the time of the first interview, but did not show any significant difference in the ratings of the administered scales at baseline.

The second interview was administered a mean of 278 days after the first interview (SD 27.7, median 283). Only the patients and caregivers who underwent both examinations were included in the calculations. All demographic data are referred to the time of the first interview.

Patients.

The demographics of the 31 patients are reported in table 1. Two patients (6.4%) were tracheostomized, 6 (19.3%) received enteral nutrition via percutaneous endoscopic gastrostomy or radiologic inserted gastrostomy, and 8 (25.8%) were using NIV. The mean ALS-FRS score was 28.7 (SD 7) at baseline, and 24.1 (SD 6.9) at the second interview (p = 0.0001) (table 2). The mean MQoL score was 6.8 (SD 1.6) at baseline and 7 (SD 1.1) at the second interview (p = 0.069) (table E-1 on the Neurology Web site at www.neurology.org); although all MQoL scores improved from the first to the second interview, only the Support subscale showed a significant increase. The mean ZDS score was 43.2 (SD 8.7) at baseline and 45.7 (9.3) at the second interview (p = 0.104, NS). Depression (ZDS score ≥ 50) was found in 6 patients (5 mild, 1 moderate) at baseline (19.3%) and in 10 (8 mild and 2 moderate) at the second interview (32.3%) (p = 0.192). There was a correlation between ZDS scores and MQoL scores in both interviews (first interview, r = −0.79, p = 0.00001; second interview, r = −0.49, p = 0.005). The mean SPBS score was 71.2 (SD 22.0) at baseline and 72.3 (SD 18.0) at the second interview (p = 0.721).

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1 Demographics of patients and caregivers

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 2 Patients’ mean ALS-FRS total scores

Caregivers.

The demographics of the 31 caregivers are reported in table 1. The caregivers’ mean MQoL score was 7.3 (SD 1.1) at baseline and 6.9 (1.5) at the second interview (p = 0.133). The mean ZDS scores were 38.9 (SD 8.1) at baseline and 42.2 (SD 8.7) at the second interview (p = 0.025). Depression (ZDS score ≥ 50) was found in 3 caregivers at the first testing (9.7%) and in 6 at the second (19.3%) (p = 0.236). In all instances the depression was mild. There was a correlation between caregivers’ ZDS scores and MQoL scores at both interviews (first interview, r = −0.65, p = 0.0001; second interview, r = −0.71, p = 0.00001). The mean CBI score increased from 50.3 (SD 17.6) at baseline to 55.8 (SD 16.4) at the second interview (p = 0.033). ZDS and CBI scores were not influenced by the fact that the caregiver was the spouse or a different relative, or by the gender of the caregiver. Caregivers’ mean MQoL is reported in table E-2. CBI subscales scores are shown in table 3; only the Physical symptoms subscale of the MQoL and the Emotional burden subscale of the CBI significantly worsened from the first to the second interview.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 3 Caregivers’ mean CBI scores

Correlations.

Patients’ ZDS and SPBS were correlated both at baseline (r = 0.74; p = 0.00001) and at second testing (r = 0.40; p = 0.03). At baseline, caregivers’ ZDS score was significantly correlated with CBI and all its subscales, but for Emotional Burden (data not shown); at the second assessment, caregivers’ ZDS score was significantly correlated to both CBI total score and all its subscores (data not shown). The correlation between patients’ and caregivers’ ZDS was significant at baseline (r = 0.46; p = 0.009), but not at the second testing (r = 0.31; p = 0.09). At the first interview, two patient–caregiver couples were concordant for depression, whereas at the second interview four couples were concordant for depression, i.e., had a ZDS score over 50. Caregivers’ age and gender had no influence on any of the considered variables. CBI and ALS-FRS were correlated, both at the first (r = −0.61, p = 0.0003) and at the second testing (r = −0.64, p = 0.0001); in particular, CBI was correlated to upper limbs and lower limbs symptoms, but not to bulbar symptoms and respiration. CBI and SPBS were correlated both at the first testing (r = 0.41; p = 0.02), and at the second testing (r = 0.38; p = 0.03). SPBS was not correlated to ALS-FRS total scores and its subscales, whereas patients’ MQoL total scores were slightly correlated to ALS-FRS at the first testing (r = 0.38, p = 0.03), but not at the second testing (r = 0.34, p = 0.06). Conversely, caregivers’ MQoL was not correlated to patients’ ALS-FRS score both at the first (r = 0.35, p = 0.06) and at the second assessment (r = 0.31, p = 0.09).

Discussion.

In a previous cross-sectional study, we have found that patients’ level of disability, especially at spinal level, and caregivers’ depression were the factors with the strongest correlation with caregivers’ burden; patients’ feeling to be a burden, measured with SPBS, correlated with their own depression, but not with their level of physical impairment.9 In the present longitudinal study, we found that caregivers’ overall psychological well-being worsened over time, whereas the patients’ remained relatively stable: the correlation between patients’ ZDS and SPBS weakened at the second testing, while the correlation between caregivers’ ZDS and CBI got more significant; more importantly, quality of life was higher in caregivers than in patients at baseline, but became higher in patients at the second testing. The steadiness of patients’ QoL during the course of ALS, despite the worsening of clinical status, has also been found in other studies.15,16 In one study, after 1 year of follow-up, patients maintained a positive self-perception of their health despite physical deterioration, and QoL was significantly related to self-perception of health and religiosity.15 A more recent article found that the patients did not assess their QoL before the start of symptoms differently at the reassessments later in the course of the disorder, indicating that there was no tendency to glorify life before the symptoms started as the disease progressed.16 The substantial steadiness of QoL and the non-significant increase of depression in patients over time may be due to several factors: patients’ acceptance of and adjustment to the disease over time and with the approach of death,6,16,17 use of denial18 as well as optimism, flexibility, and humor as psychological defenses,19 or a reduction of insight, related to patients’ subtle cognitive impairment.20,21

Caregivers reported a reduction of QoL, although not significant. The most impaired caregivers’ MQoL domain was Psychological Health, but the only domain showing a significant decrease over time was Physical Symptoms. For patients, as one would expect, the most impaired QoL domain was Physical Symptoms, even though its score did not worsen over time, while the actual physical symptoms, measured by the ALS-FRS, did; this might be due either to patients’ reframing, or to a neglect toward their actual status. On the contrary, the significant increase of the QoL Support domain for patients with ALS may indicate that they positively perceive the help, both physical and psychological, they receive from their caregivers.

The significant increase of caregivers’ burden and the reduction of their QoL between the two examinations is likely to be related to the accumulation of stress and fatigue over time,22 as also indicated by the significant increase of the Emotional Burden subscore of the CBI. However, interestingly, the most impaired CBI domain, both at baseline and at second interview, was Time-dependence Burden, confirming that the limitation of time for oneself is the main source of caregivers’ dissatisfaction.9,23

Patients seem to be aware that their caregivers get more and more burdened over time,9,22 but this understanding does not appear to be complete, since the SPBS scores did not modify between the two interviews, despite the significant increase of caregivers’ burden. This discrepancy could indicate that the patients’ concept of burden is somehow different from what is experienced by their caregivers.24,25

Caregivers’ depression increased over time proportionally more than patients’, even though the absolute scores of the former remained lower than those of the latter. An increase of depression over time among caregivers was found in a recent prospective study, which assessed the caregivers two times over 1 year.26 In the same article, overall caregivers’ psychological distress (a composite measure combining mood, burden, and strain) was found to increase significantly aver time. In our study 9.7% of caregivers at baseline and 19.3% after 9 months had scores over the cut-point of 50, indicating a mild to moderate depression. Similarly, in another article, 9.5% of caregivers were classified as depressed at baseline, 14.3% after a mean of 6 months and 19.0% after a mean of 12 months.26

While QoL of patients with ALS has been largely investigated, relatively few studies have assessed caregivers’ QoL, and their coping and adaptation issues. Some studies9,23 have pointed out the lack of leisure time and the impossibility to go out of the home, participate in social activities, see friends, and take care of their own needs as the main sources of caregivers’ concerns. Even though most caregivers did not feel that their patients’ requests were excessive or unreasonable, some of them never reach a successful adaptation.23 Also the changes in relationships that occur between patients and significant others during the course of the disease may be devastating for caregivers.27 A study28 has classified caregivers’ unfavorable life conditions into seven categories: defenselessness, negative affection, hopelessness, sadness, depression, isolation, and loneliness. Another study has pointed out that 86.4% of patients and 79.7% of caregivers endorsed existential issues as their main stressors, followed by physical concerns (patients, 80.3%, and caregivers, 76.3%), and by psychological factors (38% both in patients and caregivers).24 Finally, a recent study has found that psychological distress in ALS caregivers was related to negative social support and their baseline satisfaction with their social relationships.26

ALS is considered a family disease, meaning that it involves every member of the patient's entourage. Moreover, some evidence shows that caregivers’ mental status has great influence on patients, in terms of physical, psychological, and existential well being3,9; therefore, any planning regarding ALS care should not overlook caregivers’ physical and psychological conditions, together with their coping abilities and needs.

Accordingly, interventions specifically designed to enhance the communication effectiveness between patients and caregivers might improve the psychological well-being of both parties, helping patients to be more aware of their caregivers’ needs, and caregivers to get more apt to accept their straining but invaluable role.29 Such interventions should require a psychological follow-up, including serial neuropsychological assessments of patients’ mental status where possible,30 in order to establish whether patients actually lack empathy necessary to feel and understand their caregivers’ distress, and to help caregivers coping with such a challenging task, by providing them a deeper knowledge about the psychological status of the persons they care for.

Footnotes

  • Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the March 20 issue to find the title link for this article.

    †Deceased.

    Supported by Ricerca Sanitaria Finalizzata, Regione Piemonte, 2004.

    Disclosure: The authors report no conflicts of interest.

    Received June 29, 2006. Accepted in final form November 21, 2006.

References

  1. 1.↵
    Grossman A, Bradley W. Psychosocial factors and cognition in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:217–224.
    OpenUrlPubMed
  2. 2.↵
    Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci 1997;152(Suppl 1):75–79.
    OpenUrlCrossRef
  3. 3.↵
    Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000;62:271–279.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Chiò A, Gauthier A, Montuschi A, et al. A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry 2004;75:1597–1601.
    OpenUrlAbstract/FREE Full Text
  5. 5.
    Kubler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair 2005;19:182–193.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Bungener C, Piquard A, Pradat P-F, Salachas F, Meininger V, Lacomblez L. Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. ALS 2005;6:221–225.
    OpenUrl
  7. 7.↵
    Chipcase SY, Lincoln NB. Factors associated with carer strain in carers of people with multiple sclerosis. Disability Rehabil 2001;23:768–776.
    OpenUrl
  8. 8.
    Thommessen B, Aarsland D, Braekhus A, Oksengaard AR, Engedal K, Laake K. The psychological burden on spouses of the elderly with stroke, dementia and Parkinson's disease. Int J Ger Psych 2002;17:78–84.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Chiò A, Gauthier A, Calvo A, Ghiglione P, Mutani R. Caregiver burden and patients’ perception of being a burden in ALS. Neurology 2005;64:1780–1782.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–299.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63–70.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Cousineau N, McDowell I, Hotz S, Hébert P. Measuring chronic patients’ feeling to be a burden to their caregivers. Medical Care 2003;41:110–118.
    OpenUrlCrossRefPubMed
  13. 13.↵
    Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995;9:207–219.
  14. 14.↵
    Novak M, Guest C. Application of a multidimensional caregiver burden inventory. Gerontologist 1989;29:798–803.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Bremer BA, Walsh S, Simmons Z, Felgoise SH. Factors supporting quality of life over time for individuals with amyotrophic lateral sclerosis: the role of positive self-perception and religiosity. Ann Behav Med 2004;28:119–125.
    OpenUrlPubMed
  16. 16.↵
    Nygren I, Askmark H. Self-reported quality of life in amyotrophic lateral sclerosis. J Pall Med 2006;9:304–308.
    OpenUrlPubMed
  17. 17.
    Hardiman O, Hickey A, O’Donerty LJ. Physical decline and quality of life in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:230–234.
    OpenUrlPubMed
  18. 18.↵
    Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neurone disease. J Neurol Sci 1998;160(suppl 1):S53–S56.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Nelson ND, Trail M, Van JN, Appel SH, Lai EC. Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources and illness characteristics. J Palliat Med 2003;6:417–424.
    OpenUrlCrossRefPubMed
  20. 20.↵
    Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077–1079.
    OpenUrlAbstract/FREE Full Text
  21. 21.
    Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586–590.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Hecht MJ, Graesel E, Tiggers S, et al. Burden of care in amyotrophic lateral sclerosis. Palliat Med 2003;17:327–333.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Gelinas DF, O’Connor P, Miller RG. Quality of life for ventilator-dependent ALS patients and their caregivers. J Neurol Sci 1998;160(suppl 1):134–136.
    OpenUrl
  24. 24.↵
    Trail M, Nelson ND, Van JN, Appel SH, Lai EC. Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregivers. ALS 2004;5:40–45.
    OpenUrl
  25. 25.
    Adelman EE, Albert SM, Rabkin JG, Del Bene ML, Tider T, O'sullivan I. Disparities in perception of distress and burden in ALS patients and family caregivers. Neurology 2004;62:1766–1770.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    Goldstein LH, Atkins L, Landau S, Brown R, Leigh NP. Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis. Psychol Med 2006;36:865–875.
    OpenUrlCrossRefPubMed
  27. 27.↵
    Goldstein LH, Leigh PN. Motor neuron disease: a review of its emotional and cognitive consequences for patients and its impact on carers. Br J Health Psychol 1999;4:193–208.
    OpenUrl
  28. 28.↵
    Paz-Rodriguez F, Andrade-Palos P, Llanos-Del Pilar AM. Consecuencias emocionales del cuidado del paciente con esclerosis lateral amiotrofica. Rev Neurol 2005;40:459–564.
    OpenUrlPubMed
  29. 29.↵
    Ball JL, Beukelman DR, Patte GL. Communication effectiveness in amyotrophic lateral sclerosis. J Commun Disord 2004;37:197–215.
    OpenUrlCrossRefPubMed
  30. 30.↵
    Barson FP, Kinsella GJ, Ong B, Mathers SE. A neuropsychological investigation of dementia in motor neuron disease (MND). J Neurol Sci 2000;180:107–113.
    OpenUrlCrossRefPubMed

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Topics Discussed

  • Amyotrophic lateral sclerosis
  • Quality of life
  • Depression

Alert Me

  • Alert me when eletters are published
Neurology: 98 (24)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise